Shandong Kexing Bioproducts Co,.Ltd (688136.SS)
CNY 35.33
(0.8%)
CNY 35.33
(0.8%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.25 Billion CNY | -4.32% |
| 2022 | 1.31 Billion CNY | 2.39% |
| 2021 | 1.28 Billion CNY | 5.32% |
| 2020 | 1.22 Billion CNY | 2.48% |
| 2019 | 1.19 Billion CNY | 33.7% |
| 2018 | 890.61 Million CNY | 44.62% |
| 2017 | 615.84 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 278.36 Million CNY | -29.72% |
| 2024 Q1 | 360.66 Million CNY | 24.35% |
| 2024 Q2 | 396.07 Million CNY | 9.82% |
| 2023 Q2 | 326.32 Million CNY | 1.14% |
| 2023 FY | 1.25 Billion CNY | -4.32% |
| 2023 Q3 | 320.03 Million CNY | -1.93% |
| 2023 Q1 | 322.63 Million CNY | -13.24% |
| 2023 Q4 | 290.03 Million CNY | -9.37% |
| 2022 Q3 | 314.62 Million CNY | -12.52% |
| 2022 Q2 | 359.66 Million CNY | 33.35% |
| 2022 Q1 | 269.71 Million CNY | -30.66% |
| 2022 FY | 1.31 Billion CNY | 2.39% |
| 2022 Q4 | 371.86 Million CNY | 18.19% |
| 2021 FY | 1.28 Billion CNY | 5.32% |
| 2021 Q3 | 300.8 Million CNY | -5.52% |
| 2021 Q4 | 388.94 Million CNY | 29.3% |
| 2021 Q1 | 277.04 Million CNY | -15.76% |
| 2021 Q2 | 318.37 Million CNY | 14.92% |
| 2020 Q3 | 325.21 Million CNY | 47.36% |
| 2020 FY | 1.22 Billion CNY | 2.48% |
| 2020 Q4 | 328.89 Million CNY | 1.13% |
| 2020 Q2 | 220.68 Million CNY | -36.13% |
| 2020 Q1 | 345.5 Million CNY | 5.24% |
| 2019 Q3 | 320.08 Million CNY | 0.0% |
| 2019 FY | 1.19 Billion CNY | 33.7% |
| 2019 Q4 | 328.3 Million CNY | 2.57% |
| 2018 FY | 890.61 Million CNY | 44.62% |
| 2017 FY | 615.84 Million CNY | 0.0% |